首页> 外文期刊>The Journal of Physiology >Transient impairment of the axolemma following regional anaesthesia by lidocaine in humans
【24h】

Transient impairment of the axolemma following regional anaesthesia by lidocaine in humans

机译:利多卡因对人进行局部麻醉后对腋窝的短暂损伤

获取原文
获取原文并翻译 | 示例
       

摘要

The local anaesthetic lidocaine is known to block voltage-gated Na+ channels (VGSCs), although at high concentration it was also reported to block other ion channel currents as well as to alter lipid membranes. The aim of this study was to investigate whether the clinical regional anaesthetic action of lidocaine could be accounted for solely by the block of VGSCs or whether other mechanisms are also relevant. We tested the recovery of motor axon conduction and multiple measures of excitability by 'threshold-tracking' after ultrasound-guided distal median nerve regional anaesthesia in 13 healthy volunteers. Lidocaine caused rapid complete motor axon conduction block localized at the wrist. Within 3 h, the force of the abductor pollicis brevis muscle and median motor nerve conduction studies returned to normal. In contrast, the excitability of the motor axons at the wrist remained markedly impaired as indicated by a 7-fold shift of the stimulus-response curves to higher currents with partial recovery by 6 h and full recovery by 24 h. The strength-duration properties were abnormal with markedly increased rheobase and reduced strength-duration time constant. The changes in threshold during electrotonus, especially during depolarization, were markedly reduced. The recovery cycle showed increased refractoriness and reduced superexcitability. The excitability changes were only partly similar to those previously observed after poisoning with the VGSC blocker tetrodotoxin. Assuming an unaltered ion-channel gating, modelling indicated that, apart from up to a 4-fold reduction in the number of functioning VGSCs, lidocaine also caused a decrease of passive membrane resistance and an increase of capacitance. Our data suggest that the lidocaine effects, even at clinical 'sub-blocking' concentrations, could reflect, at least in part, a reversible structural impairment of the axolemma.
机译:已知局部麻醉剂利多卡因可阻断电压门控的Na +通道(VGSC),尽管据报道在高浓度下它也可阻断其他离子通道电流并改变脂质膜。这项研究的目的是调查利多卡因的临床区域麻醉作用是否可以仅由VGSC阻断来解释,或者其他机制是否也相关。我们在13位健康志愿者的超声引导下远端正中神经区域麻醉后,通过“阈值跟踪”测试了运动轴突传导的恢复和兴奋性的多种测量方法。利多卡因引起快速完全运动轴突传导阻滞位于手腕。 3小时内,外展肌短缩肌的力量和正中运动神经传导研究恢复正常。相反,运动轴突在手腕处的兴奋性仍然明显受损,这是由刺激响应曲线向较高电流的7倍偏移所表明的,部分恢复6 h,完全恢复24 h。强度持续时间特性异常,流变碱显着增加,强度持续时间常数降低。在电渗过程中,尤其是在去极化过程中,阈值的变化明显减少。恢复周期显示出增加的耐火度和降低的超兴奋性。兴奋性变化仅部分类似于先前用VGSC阻断剂河豚毒素中毒后观察到的变化。假设离子通道门控未发生变化,建模表明,除了功能性VGSC的数量减少多达4倍之外,利多卡因还引起了被动膜电阻的降低和电容的增加。我们的数据表明,即使在临床“亚阻滞”浓度下,利多卡因的作用也可能至少部分反映了阿索莫姆的可逆结构损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号